China, Sept. 16 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A prospective study on the treatment of severe patients with NTIS by thyroid hormone supplementation therapy'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600132530
Registration Time: 2026/09/15
Type: Interventional study
Primary Sponsor: Northern Jiangsu People's Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=297339
Published by HT Digital Content Services with permission from Health Daily Digest....